JP2011502137A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502137A5 JP2011502137A5 JP2010531449A JP2010531449A JP2011502137A5 JP 2011502137 A5 JP2011502137 A5 JP 2011502137A5 JP 2010531449 A JP2010531449 A JP 2010531449A JP 2010531449 A JP2010531449 A JP 2010531449A JP 2011502137 A5 JP2011502137 A5 JP 2011502137A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- domain
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98360607P | 2007-10-30 | 2007-10-30 | |
| US60/983,606 | 2007-10-30 | ||
| PCT/EP2008/009070 WO2009056268A1 (en) | 2007-10-30 | 2008-10-27 | An antigen associated with rheumatoid arthritis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012219986A Division JP6154594B2 (ja) | 2007-10-30 | 2012-10-02 | 関節リウマチと関連する抗原 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011502137A JP2011502137A (ja) | 2011-01-20 |
| JP2011502137A5 true JP2011502137A5 (enExample) | 2012-08-30 |
| JP5106635B2 JP5106635B2 (ja) | 2012-12-26 |
Family
ID=40282320
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010531449A Active JP5106635B2 (ja) | 2007-10-30 | 2008-10-27 | 関節リウマチと関連する抗原 |
| JP2012219986A Active JP6154594B2 (ja) | 2007-10-30 | 2012-10-02 | 関節リウマチと関連する抗原 |
| JP2014210887A Active JP6198703B2 (ja) | 2007-10-30 | 2014-10-15 | 関節リウマチと関連する抗原 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012219986A Active JP6154594B2 (ja) | 2007-10-30 | 2012-10-02 | 関節リウマチと関連する抗原 |
| JP2014210887A Active JP6198703B2 (ja) | 2007-10-30 | 2014-10-15 | 関節リウマチと関連する抗原 |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US8222377B2 (enExample) |
| EP (3) | EP2209805B1 (enExample) |
| JP (3) | JP5106635B2 (enExample) |
| KR (3) | KR101608544B1 (enExample) |
| CN (2) | CN101918443B (enExample) |
| AU (1) | AU2008317941B2 (enExample) |
| BR (1) | BRPI0818272B8 (enExample) |
| CA (1) | CA2704296C (enExample) |
| DK (2) | DK2209805T3 (enExample) |
| ES (2) | ES2646228T3 (enExample) |
| HU (2) | HUE037036T2 (enExample) |
| MX (1) | MX2010004726A (enExample) |
| NO (1) | NO2209805T3 (enExample) |
| PL (2) | PL2209805T3 (enExample) |
| PT (2) | PT3281952T (enExample) |
| RU (2) | RU2486198C2 (enExample) |
| SI (2) | SI3281952T1 (enExample) |
| WO (1) | WO2009056268A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070084556A1 (en) | 2005-10-14 | 2007-04-19 | Langseder Neal E | Method of applying a label to a squeeze tube |
| CA2682851C (en) | 2007-04-02 | 2017-01-17 | Philogen S.P.A. | A novel antigen associated with the neovasculature of tumour metastases |
| US10202442B2 (en) | 2007-07-25 | 2019-02-12 | Philogen S.P.A. | Antigen associated with lung cancers and lymphomas |
| EP2209805B1 (en) | 2007-10-30 | 2017-09-06 | Philogen S.p.A. | An antigen associated with rheumatoid arthritis |
| EP2379116B1 (en) | 2009-01-07 | 2015-08-26 | Philogen S.p.A. | Antigens associated with endometriosis |
| US8679488B2 (en) | 2009-08-05 | 2014-03-25 | Philogen S.P.A. | Targeting of bone marrow neovasculature |
| ES2872964T3 (es) * | 2011-07-27 | 2021-11-03 | Philogen Spa | Inmunoconjugado de IL-12 |
| US9346872B2 (en) * | 2012-08-08 | 2016-05-24 | Roche Glycart Ag | Interleukin-10 fusion proteins |
| TWI499426B (zh) * | 2012-09-27 | 2015-09-11 | Philogen Spa | 與發炎性腸病有關之抗原 |
| EP2903629B1 (en) * | 2012-10-03 | 2019-07-10 | Philogen S.p.A. | Antibody conjugate for use in treating inflammatory bowel disease |
| BR112016016658A2 (pt) * | 2014-02-06 | 2018-01-23 | F. Hoffmann-La Roche Ag | proteína de fusão de um anticorpo, polinucleotídeo, vetor, célula hospedeira, composição farmacêutica, métodos para produzir uma proteína de fusão e de tratamento de uma doença em um indivíduo e uso da proteína de fusão |
| GB201507908D0 (en) | 2015-05-08 | 2015-06-24 | Philogen Spa | IL2 and TNF immunoconjugates |
| RU2018105687A (ru) | 2015-07-16 | 2019-08-16 | Филоджен С.П.А. | Иммуноконъюгаты на основе il22 |
| US20190309060A1 (en) | 2016-01-15 | 2019-10-10 | Philogen S.P.A. | Intestinal antigens for pharmacodelivery applications |
| JP2017197558A (ja) * | 2017-06-07 | 2017-11-02 | フィロゲン エスピーエー | 炎症性腸疾患に関連する抗原 |
| EP3634999A1 (en) | 2017-06-07 | 2020-04-15 | Philogen S.p.A. | Vascular endothelial growth factor/anti-fibronectin antibody fusion proteins |
| CN113811549A (zh) | 2019-02-21 | 2021-12-17 | Xencor股份有限公司 | 非靶向和靶向性il-10 fc融合蛋白 |
| CN114072164A (zh) * | 2019-03-06 | 2022-02-18 | 德卡生物科学公司 | Il-10变体分子和治疗炎性疾病和肿瘤的方法 |
| WO2020249757A1 (en) | 2019-06-14 | 2020-12-17 | Philogen S.P.A | Immunoconjugates comprising a single chain diabody and interleukin-15 or interleukin-15 and a sushi domain of interleukin-15 receptor alpha |
| CN116322785A (zh) | 2020-07-20 | 2023-06-23 | 德卡生物科学公司 | 包含il-10的双细胞因子融合蛋白 |
| EP4185615A1 (en) | 2020-07-22 | 2023-05-31 | Philogen S.p.A. | Treatment of pulmonary hypertension |
| CN113480636B (zh) * | 2021-06-23 | 2023-11-03 | 烟台科瑞斯生物技术有限责任公司 | 重组人纤连蛋白及其制备、活性测定和稳定性实验方法 |
| US20250197485A1 (en) | 2022-03-17 | 2025-06-19 | Universitätsklinikum Jena | Anti-ED-A Antibodies for the Treatment of Pulmonary Hypertension |
| WO2026003203A1 (en) | 2024-06-27 | 2026-01-02 | Philogen S.P.A. | Combination of an immunocytokine comprising targeted il2 and a jak inhibitor |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IT1217724B (it) | 1988-05-26 | 1990-03-30 | Ist Naz Ric Sul Cancro | Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori |
| US5420012A (en) | 1989-05-08 | 1995-05-30 | Locus Genex Oy | Method for the detection of reactive conditions |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| WO1992017604A1 (fr) * | 1991-03-26 | 1992-10-15 | Otsuka Pharmaceutical Factory, Inc. | Anticorps monoclonal anti-eda |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5962255A (en) | 1992-03-24 | 1999-10-05 | Cambridge Antibody Technology Limited | Methods for producing recombinant vectors |
| US5871907A (en) | 1991-05-15 | 1999-02-16 | Medical Research Council | Methods for producing members of specific binding pairs |
| US6492160B1 (en) | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5872215A (en) | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| US5644033A (en) | 1992-12-22 | 1997-07-01 | Health Research, Inc. | Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| AU6098994A (en) | 1993-01-27 | 1994-08-15 | Duke University | Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
| US6054312A (en) | 1997-08-29 | 2000-04-25 | Selective Genetics, Inc. | Receptor-mediated gene delivery using bacteriophage vectors |
| DE69941267D1 (de) | 1998-12-10 | 2009-09-24 | Bristol Myers Squibb Co | Proteingerüste für antikörper-nachahmer und andere bindende proteine |
| US8623373B2 (en) | 2000-02-24 | 2014-01-07 | Philogen S.P.A. | Compositions and methods for treatment of angiogenesis in pathological lesions |
| CA2404919A1 (en) * | 2000-04-06 | 2002-10-01 | Kyowa Hakko Kogyo Co. Ltd. | Diagnostic and therapeutic agents for rheumatoid arthritis |
| AU5867901A (en) | 2000-05-04 | 2001-11-12 | Philogen S.R.L. | Method for detecting tumors |
| US20020197700A1 (en) * | 2000-09-07 | 2002-12-26 | Schering Ag | Receptor of the EDb-fibronectin domains |
| US6780594B2 (en) | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| IT1317108B1 (it) | 2000-12-06 | 2003-05-26 | Philogen Srl | Processo per la selezione di frammenti anticorporali anti-angiogenesi,frammenti anticorpali anti-angiogenesi cosi' ottenuti e loro uso. |
| US20020187100A1 (en) | 2000-12-21 | 2002-12-12 | David Rizzieri | Anti-tenascin monoclonal antibody therapy for lymphoma |
| EP1224943A1 (en) | 2001-01-19 | 2002-07-24 | Crucell Holland B.V. | Fibronectin as a tumor marker detected by phage antibodies |
| GB0209896D0 (en) | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
| WO2004000216A2 (en) | 2002-06-21 | 2003-12-31 | Duke University | Anti-tenascin antibody fragments and minibodies for treatment of lymphoma |
| KR20050065587A (ko) * | 2002-10-08 | 2005-06-29 | 이뮤노메딕스, 인코오포레이티드 | 항체 치료법 |
| CA2508831C (en) | 2002-12-13 | 2012-05-01 | Immunomedics, Inc. | Immunoconjugates with an intracellularly-cleavable linkage |
| US20040202666A1 (en) | 2003-01-24 | 2004-10-14 | Immunomedics, Inc. | Anti-cancer anthracycline drug-antibody conjugates |
| CA2523452A1 (en) | 2003-04-22 | 2004-11-04 | A & G Pharmaceutical, Inc. | Cancer specific monoclonal antibodies |
| WO2005009366A2 (en) | 2003-07-24 | 2005-02-03 | Cornell Research Foundation, Inc. | Restoring vascular function |
| EP1660519B1 (en) | 2003-07-29 | 2014-05-14 | Immunomedics, Inc. | Conjugates comprising 2-[18F]fluoro-2-deoxy-D-glucose and a peptide molecule |
| CA2552590A1 (en) | 2004-01-05 | 2005-07-21 | Emd Lexigen Research Center Corp. | Interleukin-12 targeted to oncofoetal fibronectin |
| US20060024722A1 (en) * | 2004-07-30 | 2006-02-02 | Mark Fischer-Colbrie | Samples for detection of oncofetal fibronectin and uses thereof |
| US7785591B2 (en) * | 2004-10-14 | 2010-08-31 | Morphosys Ag | Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
| SI1817345T1 (sl) | 2004-11-09 | 2009-10-31 | Philogen Spa | Protitelesa proti tenascinu-C |
| EP1831254B1 (en) * | 2004-12-23 | 2012-06-06 | Molmed SpA | Conjugation product |
| MX2007013875A (es) * | 2005-05-11 | 2008-01-28 | Philogen Spa | Proteinas de fusion del anticuerpo l19 contra fibronectina ed-b e interlucina 12. |
| AU2006262502A1 (en) | 2005-06-23 | 2007-01-04 | Emory Univerisity | Imaging agents |
| JP2009535372A (ja) | 2006-05-03 | 2009-10-01 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 抗ｅｄｂフィブロネクチンドメイン抗体ｌ１９−ｓｉｐ及び抗−ｅｇｆｒ−抗体の組合せ |
| JP2009536170A (ja) * | 2006-05-08 | 2009-10-08 | フィロジェン・エッセペア | 治療用の抗体標的指向サイトカイン |
| CA2682851C (en) * | 2007-04-02 | 2017-01-17 | Philogen S.P.A. | A novel antigen associated with the neovasculature of tumour metastases |
| US10202442B2 (en) | 2007-07-25 | 2019-02-12 | Philogen S.P.A. | Antigen associated with lung cancers and lymphomas |
| EA017995B1 (ru) * | 2007-07-25 | 2013-04-30 | Филоджен С.П.А. | Антиген, связанный с вариантами рака легкого и лимфомами |
| EP2209805B1 (en) * | 2007-10-30 | 2017-09-06 | Philogen S.p.A. | An antigen associated with rheumatoid arthritis |
| EP2379116B1 (en) | 2009-01-07 | 2015-08-26 | Philogen S.p.A. | Antigens associated with endometriosis |
| WO2010078945A2 (en) | 2009-01-07 | 2010-07-15 | Philogen S.P.A. | Cancer treatment |
| EP3842074A1 (en) | 2010-09-29 | 2021-06-30 | Philogen S.p.A. | Protein-drug conjugates |
| ES2872964T3 (es) | 2011-07-27 | 2021-11-03 | Philogen Spa | Inmunoconjugado de IL-12 |
| EP2903629B1 (en) | 2012-10-03 | 2019-07-10 | Philogen S.p.A. | Antibody conjugate for use in treating inflammatory bowel disease |
| EP2988784A1 (en) | 2013-04-25 | 2016-03-02 | Philogen S.p.A. | Antibody-drug conjugates |
| JP2016519111A (ja) | 2013-04-26 | 2016-06-30 | フィロゲン エスピーエー | 細胞外マトリックス成分に対する抗体にコンジュゲートしたｉｌ４ |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2008
- 2008-10-27 EP EP08844563.0A patent/EP2209805B1/en active Active
- 2008-10-27 AU AU2008317941A patent/AU2008317941B2/en active Active
- 2008-10-27 SI SI200832134T patent/SI3281952T1/sl unknown
- 2008-10-27 SI SI200831867T patent/SI2209805T1/sl unknown
- 2008-10-27 JP JP2010531449A patent/JP5106635B2/ja active Active
- 2008-10-27 PL PL08844563T patent/PL2209805T3/pl unknown
- 2008-10-27 PT PT171890288T patent/PT3281952T/pt unknown
- 2008-10-27 KR KR1020107011773A patent/KR101608544B1/ko active Active
- 2008-10-27 PL PL17189028T patent/PL3281952T3/pl unknown
- 2008-10-27 US US12/740,641 patent/US8222377B2/en active Active
- 2008-10-27 ES ES08844563.0T patent/ES2646228T3/es active Active
- 2008-10-27 EP EP20181520.6A patent/EP3783019A1/en not_active Withdrawn
- 2008-10-27 RU RU2010121874/10A patent/RU2486198C2/ru active
- 2008-10-27 DK DK08844563.0T patent/DK2209805T3/en active
- 2008-10-27 EP EP17189028.8A patent/EP3281952B1/en active Active
- 2008-10-27 CN CN2008801231862A patent/CN101918443B/zh active Active
- 2008-10-27 HU HUE08844563A patent/HUE037036T2/hu unknown
- 2008-10-27 NO NO08844563A patent/NO2209805T3/no unknown
- 2008-10-27 PT PT88445630T patent/PT2209805T/pt unknown
- 2008-10-27 KR KR1020167007916A patent/KR101836968B1/ko active Active
- 2008-10-27 KR KR1020187006283A patent/KR102002739B1/ko active Active
- 2008-10-27 HU HUE17189028A patent/HUE050038T2/hu unknown
- 2008-10-27 DK DK17189028.8T patent/DK3281952T3/da active
- 2008-10-27 CN CN201310233951.9A patent/CN103396483B/zh active Active
- 2008-10-27 BR BRPI0818272A patent/BRPI0818272B8/pt active IP Right Grant
- 2008-10-27 CA CA2704296A patent/CA2704296C/en active Active
- 2008-10-27 MX MX2010004726A patent/MX2010004726A/es active IP Right Grant
- 2008-10-27 WO PCT/EP2008/009070 patent/WO2009056268A1/en not_active Ceased
- 2008-10-27 ES ES17189028T patent/ES2807753T3/es active Active
-
2012
- 2012-06-05 US US13/489,123 patent/US9556257B2/en active Active
- 2012-10-02 JP JP2012219986A patent/JP6154594B2/ja active Active
-
2013
- 2013-04-09 RU RU2013115891A patent/RU2649368C2/ru active
-
2014
- 2014-10-15 JP JP2014210887A patent/JP6198703B2/ja active Active
-
2016
- 2016-12-15 US US15/380,167 patent/US10385121B2/en active Active
-
2019
- 2019-07-17 US US16/514,080 patent/US20190352384A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2486198C2 (ru) | Антиген, ассоциированный с ревматоидным артритом | |
| JP2022191301A5 (enExample) | ||
| JP2013121353A5 (enExample) | ||
| JP2010534237A5 (enExample) | ||
| JP2016135783A5 (enExample) | ||
| JP2010523541A5 (enExample) | ||
| JP2021501744A5 (enExample) | ||
| NZ600768A (en) | Human antibodies to human angiopoietin-like protein 4 | |
| JP2020537520A5 (enExample) | ||
| JP2011509245A5 (enExample) | ||
| JP2015503909A5 (enExample) | ||
| HRP20140108T1 (hr) | Protutijela protiv sklerostina | |
| PE20090161A1 (es) | Anticuerpos monoclonales anti cxcl13 | |
| IL259036A (en) | asct2-specific binding molecules and their uses | |
| NZ714313A (en) | Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| RU2018102606A (ru) | Молекулы, связывающиеся с psl pseudomonas, и пути их применения | |
| JP2015514110A5 (enExample) | ||
| EA201190132A1 (ru) | Гуманизированные антитела, связывающиеся с cd19, и их применение | |
| JP2014534239A5 (enExample) | ||
| JP2017526339A5 (enExample) | ||
| JP2017519501A5 (enExample) | ||
| RU2571204C3 (ru) | Специфические связывающие агенты против в7-н1 | |
| JP2012521217A5 (enExample) | ||
| IL273841B1 (en) | Antibodies targeting cd137 and methods of use thereof | |
| NZ598391A (en) | Anti-hepcidin antibodies and uses thereof |